Français
ItalianoBond Gilead Sciences 5.55% ( US375558CA99 ) in USD
| Issuer | Gilead Sciences | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  United States
|
||||
| ISIN code |
 US375558CA99 ( in USD )
|
||||
| Interest rate | 5.55% per year ( payment 2 times a year) | ||||
| Maturity | 15/10/2053 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 375558CA9 | ||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||
| Next Coupon | 15/10/2026 ( In 50 days ) | ||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CA99, pays a coupon of 5.55% per year. The coupons are paid 2 times per year and the Bond maturity is 15/10/2053 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CA99, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CA99, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||